Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Radiomics seeks to apply classical methods of image processing to obtain quantitative parameters fro...
Clinical workflows in oncology depend on predictive and prognostic biomarkers. However, the growing ...
Sarcomatoid mesothelioma is an aggressive malignancy that can be challenging to distinguish from ben...
BACKGROUND: In recent years, the fibroblast growth factor receptor (FGFR) pathway has been proven to...
Cancer is driven by distinctive sorts of changes and basic variations in genes. Recognizing cancer d...
Technical advancements significantly improve earlier diagnosis of cervical cancer, but accurate diag...
OBJECTIVE: This study evaluates the ability of several machine learning (ML) algorithms, developed u...
OBJECTIVES: To compare diagnostic performance of British Thyroid Association (BTA), American College...
Virtual population generation is an emerging field in data science with numerous applications in hea...
OBJECTIVE: To investigate oncological, surgical and functional outcomes of transoral robotic surgery...
Despite being standard tools for decision-making, the European Organisation for Research and Treatme...
Machine learning (ML) holds great promise for impacting healthcare delivery; however, to date most m...
This article aims to build deep learning-based radiomic methods in differentiating vessel invasion f...
Breast tumor classification with multiple medical reports such as B-ultrasound, Mammography (X-ray) ...
Bladder cancer is one of the top 10 frequently occurring cancers and leads to most cancer deaths wor...
INTRODUCTION: Multiplex biomarker analysis of cytological body fluid specimens is often used to assi...
Deep learning has emerged as the technique of choice for identifying hidden patterns in cell imaging...
Preoperative assessment of the proximity of critical structures to the tumors is crucial in avoiding...
Ground robotic vehicles are often deployed to inspect areas where radioactive floor contamination is...
Pharmaceutical agents in oncology currently have high attrition rates from early to late phase clini...
BACKGROUND: Efforts are ongoing to try and find ways to reduce the number of unnecessary prostate bi...